Servier

🎉 On this #InternationalHappinessDay, we take pride in fostering a workplace that values well-being and engagement. We are proud to have received the Gallup Exceptional Workplace Award for the second consecutive year in 2025. 🏆 With an engagement score of 4.33 out of 5 and 83% of employees recommending Servier, this recognition reflects our ongoing commitment to creating a thriving and engaging work environment. More at 👉 servier.com #WeAreServier #MovedByYou #HappyAtWork

🔵 This month, we continue to support Colorectal Cancer Awareness Month. Through the SHAPE program, we’re committed to empowering patients with mCRC with co‑created resources to support daily care needs. 📚 Explore patient brochures: f.mtr.cool/buhccaloay 🙌 Join us in supporting the @dice_europe campaign — “This March, let’s move together to reduce the risk of colorectal cancer.” #BlueMarch #ECCAM2026 #ColorectalCancer #Oncology #WeAreServier #UnitedByUnique #MovedByYou #CancerAwareness

🌍 At Servier, patient engagement is a long-term commitment. Our Patient Advisory Committee now brings together patient experts from 15 countries, co‑creating insights on treatment adherence in cardiovascular disease. 🔗 f.mtr.cool/jmmzszgmjd #PatientEngagement #PatientExpert #WeAreServier

💊 Non-adherence is widespread, but it isn’t inevitable. Evidence shows that what happens at treatment initiation plays a critical role in long-term adherence. This #WorldAdherenceDay, we’re encouraging healthcare professionals to treat adherence as a modifiable risk factor and support patients from day one. 👉 Learn more: f.mtr.cool/ovoojckfod #StayOnTrack #DontMissaMoment #MovedByYou #ClinicalRisk #PatientSupport #Prevention #BetterOutcomes @worldheartfed

🤔 Do you remember Valeria? We met her last year, during Blue March. Valeria has colon cancer and has made raising awareness her priority. She wants to talk about the fact that this type of cancer does not only affect people aged 70 and over. 📖 Read Valeria’s story 👉 f.mtr.cool/hayooqsqlu You can also find Valeria @valeriatanzt on Instagram. #HealthJourney #BlueMarch #ColorectalCancer #ECCAM26 #PatientsVoice #WeAreServier #MovedByYou @dice_europe

💙 Show your support for European Colorectal Cancer Awareness Month! Create your own personalized awareness visual using our image generator — add your logo and help amplify the message on screening and healthy ageing. 👉 f.mtr.cool/yzemibbbjx 🙌 Join us in supporting the @dice_europe campaign — “This March, let’s move together to reduce the risk of colorectal cancer.” #UnitedByUnique #BlueMarch #ECCAM2026 #ColorectalCancer #Oncology #WeAreServier #MovedByYou #CancerAwareness

🌟 At Servier, we accelerate our digital transformation!  Our ambition is clear: to become best-in-class by leveraging digital technology, data, and AI to organically integrate this technological revolution.  In alignment with our #Servier2030 ambition, we are dedicating 50% of our data and AI resources to advance our research and expedite the discovery and availability of new treatments. One of our objectives is to reduce the current average 10- to 15-year development time for a new medicine by two to four years. Read more about our digital transformation 🔗 f.mtr.cool/whdorszjlm #DigitalTransformation #AI #WeAreServier #MovedByYou

🗣️ “Without that scan, I never would have known. That scan saved my life.” Marcus is a 40-year-old Australian who had no symptoms until January 2021, when a seemingly minor accident radically changed the course of his life. That day, he broke his leg in a fall while water skiing. At the hospital, a full scan was performed, as it is the standard procedure in such cases. Healthcare professionals quickly detected a mass in his brain. It was an unexpected but decisive discovery. 📖 Read the full story of Marcus 🔗 f.mtr.cool/fqliygkmvs #Glioma #PatientsVoice #Insights #WeAreServier #MovedByYou

🌿 Our 2024/2025 #Sustainability Report is now available! This report outlines our sustainability roadmap and highlights the significant progress we have made during the fiscal year. At Servier, Sustainability is rooted in our vocation as a pharmaceutical Group committed to therapeutic progress to serve patient needs. As a Group governed by a foundation, we naturally adopt a long-term perspective that shapes our decisions and actions. We maximize our health impact by serving Patients, People and the Planet 🌍. 📖 Discover the full report here: f.mtr.cool/pctcwjclqm #WeAreServier #MovedByYou

We’re proud to become the first global pharmaceutical partner of @WomenInTech_SA  — a milestone announced at @UNESCO. Together, we aim to advance gender equality in STEM and support 5M women & girls by 2030. 🤝 Through mentoring, training programs, hackathons, and the engagement of our teams across countries: we aim to create real opportunities that will inspire the next generation of female leaders in science and technology. Learn more 🔗 f.mtr.cool/wfvtujcbua #STEM #GenderEquality #WeAreServier #MovedByYou

📢 We’ve entered into an agreement with @DayOneBio to expand our portfolio and strengthen our global capabilities in rare oncology. 🌍 Together, we aim to advance rare cancer care 🎗️ and expand our pipeline, specifically in glioma. 🧬 Learn more about this potential acquisition 🔗 f.mtr.cool/gdgzyaowos #RareOncology #PediatricCancer #Servier2030 #MovedByYou Important or required information is provided 🔗 f.mtr.cool/psmmljqrhw

💙💜💚 We had the pleasure of speaking with Morgan, mother and full-time caregiver to Madilynn, who lives with spinocerebellar ataxia type 5 — one of the rarest forms of ataxia. Morgan shared her family’s journey through years of uncertainty, the challenges of raising a child with a rare condition, and the strength they found in honesty, resilience, and joy. 🎥 Watch her inspiring story on our Instagram account 👉 f.mtr.cool/cybpjemmrl You can also find Morgan @mightymadilynn on Instagram. #RareDiseaseDay #SCA5 #PatientsVoice #WeAreServier #MovedByYou

💙 It’s Colorectal Cancer Awareness Month! We proudly support the @DiCE_Europe campaign and co‑developed this year’s slogan: “This March, let’s move together to reduce the risk of colorectal cancer.” Colorectal cancer is the 2nd leading cause of cancer deaths in Europe, yet many cases are preventable. 🩺 Screening matters — especially for people aged 50–74. Early detection saves lives. 👉 Learn more: f.mtr.cool/lysibhlwpj #BlueMarch #ECCAM2026 #ColorectalCancer #CancerAwareness #WeAreServier #UnitedByUnique #MovedByYou

💙 March is Colorectal Cancer Awareness Month. According to @WHO, colorectal cancer is the 3rd most common cancer and the 2nd leading cause of cancer death worldwide. At Servier, oncology represents nearly 70% of our R&D investments, with 8 medicines available today and a strong pipeline of 34 R&D projects. 👉 Learn more: f.mtr.cool/ymyyjvcgwi #BlueMarch #ECCAM2026 #ColorectalCancer #Oncology #CancerAwareness #WeAreServier #UnitedByUnique #MovedByYou @dice_europe

💬 “Our objective is to make sure that customers, patients, and healthcare professionals have access to the right information at the right time via the right channels.” Meet Joséphine Perret and Yann Péoc’h, leading Servier’s global digital transformation. 🌍 📲 From building digital ecosystems to supporting teams worldwide, they make health information more accessible, relevant, and impactful for every audience. 👩‍⚕️👨‍⚕️ #WeAreServier #ProudToBeServier #DigitalHealth #Omnichannel #Teamwork #Communication

💙💜💚 At Servier, our R&D is committed to bringing therapeutic innovations to patients with rare diseases in the areas of cancer and neurology. We are committed to therapeutic progress to meet the medical needs of patients and improve their quality of life. Read the article of Nitza Thomasson, Global Head of R&D Neurology at Servier, to learn more about how science, partnership and determination can reshape the future of rare neurology 🔗 f.mtr.cool/ewuxeghoos #RareDiseaseDay #ShareYourColours #LightUpForRare #WeAreServier #MovedByYou

💙💜💚 Today is #RareDiseaseDay!  🌍 Rare diseases affect up to 300 million people globally, with over 6,000 identified—72% of which are genetic. The journey to diagnosis is often long and complex. This diagnostic odyssey can significantly impact quality of life, as individuals navigate a myriad of symptoms that vary widely. Learn more about Rare Disease Day 👉 f.mtr.cool/dyivzogunl #RareDiseaseDay #ShareYourColours #LightUpForRare #WeAreServier #MovedByYou @rarediseaseday

💙💜💚 Today is #RareDiseaseDay!  300 million people worldwide are living with a #raredisease. Unfortunately, such diseases often have a poor prognosis. It's time to raise awareness 🗣and educate your loved ones!  Learn more about Rare Disease Day 👉 f.mtr.cool/fmvuaycnks #RareDiseaseDay #ShareYourColours #LightUpForRare #WeAreServier #MovedByYou @rarediseaseday

Meet Ekaterina (Katia) Trunova, formerly Global Forecast and Market Insights Director for Cardio-Metabolic and Venous Diseases at Servier, and now promoted to Business Office Director – Cardio-Metabolism. 📊With expertise in market research and strategic insights, Katia helps teams make data-driven decisions that shape Servier’s long-term strategy. 🤝 What drives her? Collaboration, shared purpose, and the chance to learn and grow alongside inspiring colleagues every day. #WeAreServier #ProudToBeServier #MarketInsights #Forecasting #DataDriven

🎧 You're tuning into Heart Failure Realities, a podcast series focused on heart failure management, brought to you by Servier. In our latest episode, Professor Waleed Al-Habeeb and Dr. Sonia Mirabet Perez, Chief of the Heart Failure Unit at Sant Pau Hospital, explore the vital role of nurses and other stakeholders in heart failure care. Learn how collaboration can enhance patient outcomes in heart failure management. 👉 Don’t miss the full episode on YouTube! f.mtr.cool/eoumsgrput #HeartFailure #Cardiology #HeartHealth #MedicalEducation #HealthPodcast #WeAreServier #MovedByYou